Back to Agenda
Novel Therapeutic Approaches
Session Chair(s)
Dolca Thomas
Vice President Translational Medicine for Immunology, Inflammation and Infectiou, F. Hoffmann-La Roche, Switzerland
Many novel therapeutic approaches are on the horizon which the promise to address the unmet needs of patients. However, some of these approaches will challenge current approaches to drug development, regulation and the health technology assessment. A multi-stakeholder round table.
Speaker(s)
Tomasz Lawniczek, DrMed
Senior Clinical Development Medical Director, Novartis, Switzerland
Panel Discussion
Sheuli Porkess, MD, MRCP, FFPM
Executive Director Research, Medical & Innovation, The Association of the British Pharmaceutical Industry (ABPI), United Kingdom
Panel Discussion
Corinne de Vries, PHD, MA, MSC
EMA liaison official to the US FDA, European Medicines Agency, Netherlands
Panel Discussion
Niklas Hedberg, MPHARM
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Panel Discussion
Have an account?